Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T88015 | Target Info | |||
Target Name | COVID-19 3C-like protease (3CLpro) | ||||
Synonyms | COVID-19 3CL-PRO; COVID-19 3CLp; COVID-19 nsp5 | ||||
Gene Name | COVID-19 rep | ||||
Biochemical Class | Coronaviruses polyprotein 1ab family | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 4-{2-(4-Fluoro-benzyl)-6-methyl-5-[(5-methyl-isoxazole-3-carbonyl)-amino]-4-oxo-heptanoylamino}-5-(2-oxo-pyrrolidin-3-YL)-pentanoic acid ethyl ester | Ligand Info | |||
Canonical SMILES | CCOC(=O)CCC(CC1CCNC1=O)NC(=O)C(CC2=CC=C(C=C2)F)CC(=O)C(C(C)C)NC(=O)C3=NOC(=C3)C | ||||
InChI | 1S/C31H41FN4O7/c1-5-42-27(38)11-10-24(16-21-12-13-33-29(21)39)34-30(40)22(15-20-6-8-23(32)9-7-20)17-26(37)28(18(2)3)35-31(41)25-14-19(4)43-36-25/h6-9,14,18,21-22,24,28H,5,10-13,15-17H2,1-4H3,(H,33,39)(H,34,40)(H,35,41)/t21-,22+,24+,28-/m0/s1 | ||||
InChIKey | LMIUALQNZXJHOG-IFILWLFVSA-N | ||||
PubChem Compound ID | 6323208 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 7L8I SARS-CoV-2 Main Protease (Mpro) in Complex with Rupintrivir (P21) | ||||||
Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | No | [1] |
PDB Sequence |
SGFRKMAFPS
10 GKVEGCMVQV20 TCGTTTLNGL30 WLDDVVYCPR40 HVICTSEDML50 NPNYEDLLIR 60 KSNHNFLVQA70 GNVQLRVIGH80 SMQNCVLKLK90 VDTANPKTPK100 YKFVRIQPGQ 110 TFSVLACYNG120 SPSGVYQCAM130 RPNFTIKGSF140 LNGSCGSVGF150 NIDYDCVSFC 160 YMHHMELPTG170 VHAGTDLEGN180 FYGPFVDRQT190 AQAAGTDTTI200 TVNVLAWLYA 210 AVINGDRWFL220 NRFTTTLNDF230 NLVAMKYNYE240 PLTQDHVDIL250 GPLSAQTGIA 260 VLDMCASLKE270 LLQNGMNGRT280 ILGSALLEDE290 FTPFDVVRQC300 SGVTF |
|||||
|
THR24
4.977
THR25
2.179
THR26
2.469
LEU27
2.405
PRO39
2.438
HIS41
2.496
VAL42
4.283
MET49
2.624
PHE140
2.719
LEU141
3.022
ASN142
2.348
GLY143
2.522
SER144
2.524
CYS145
1.766
|
|||||
PDB ID: 7L8J SARS-CoV-2 Main Protease (Mpro) in Complex with Rupintrivir (P21212) | ||||||
Method | X-ray diffraction | Resolution | 2.45 Å | Mutation | No | [1] |
PDB Sequence |
SGFRKMAFPS
10 GKVEGCMVQV20 TCGTTTLNGL30 WLDDVVYCPR40 HVICTSEDML50 NPNYEDLLIR 60 KSNHNFLVQA70 GNVQLRVIGH80 SMQNCVLKLK90 VDTANPKTPK100 YKFVRIQPGQ 110 TFSVLACYNG120 SPSGVYQCAM130 RPNFTIKGSF140 LNGSCGSVGF150 NIDYDCVSFC 160 YMHHMELPTG170 VHAGTDLEGN180 FYGPFVDRQT190 AQAAGTDTTI200 TVNVLAWLYA 210 AVINGDRWFL220 NRFTTTLNDF230 NLVAMKYNYE240 PLTQDHVDIL250 GPLSAQTGIA 260 VLDMCASLKE270 LLQNGMNGRT280 ILGSALLEDE290 FTPFDVVRQC300 SGVTF |
|||||
|
THR25
3.702
THR26
4.464
LEU27
2.358
PRO39
2.485
HIS41
2.399
VAL42
4.198
SER46
4.942
MET49
4.400
PHE140
2.738
LEU141
2.786
ASN142
2.291
GLY143
2.290
SER144
2.588
CYS145
1.771
HIS163
2.355
HIS164
1.929
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode. Biochemistry. 2021 Oct 5;60(39):2925-2931. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.